Clinical and epidemiological characteristics of pediatric solid tumours at Sultan Agung Islamic Hospital (2018–2023)

Authors

  • Citra Primavita Mayangsari Department of Paediatrics, Faculty of Medicine, Universitas Islam Sultan Agung, Semarang, Indonesia , Department of Paediatrics, Sultan Agung Islamic Hospital, Semarang, Indonesia
  • Rudi Yuwono Raharjo Department of Paediatric Surgery, Sultan Agung Islamic Hospital, Semarang, Indonesia
  • Alinda Ardelia Faculty of Medicine, Universitas Islam Sultan Agung, Semarang, Indonesia
  • Raihan Daffa Setiyo Pramudya Faculty of Medicine, Universitas Islam Sultan Agung, Semarang, Indonesia
Published 2025-06-07
Issue Vol. 16 No. 1 (2025): June 2025
Section Original Research Articles
DOI: https://doi.org/10.30659/sainsmed.v16i1.39770
Keywords: Pediatric solid tumour, Prevalence, Blood test abnormalities, Pediatric oncology

Abstract

A tumour is an abnormal mass of tissue that does not contain cysts or fluid. According to the Global Cancer Statistics, approximately 275,000 children worldwide were diagnosed with cancer in 2022. Among pediatric solid tumours, the most common types include neuroblastoma, rhabdomyosarcoma, retinoblastoma, osteosarcoma, and Ewing sarcoma. This study aims to analyse the prevalence and characteristics of solid tumours in children treated at Sultan Agung Islamic Hospital in Semarang. A descriptive quantitative approach was employed, utilising retrospective data from medical records. The study population comprised pediatric inpatients and outpatients aged 0 to 17 years who underwent pathological or radiological examinations between 2018 and 2024. Data analysed included demographic details (age, gender), presenting symptoms, and blood test results. The study identified 22 pediatric patients with solid tumours, with Rhabdomyosarcoma and Teratoma being the most common types. The gender distribution was evenly split between males and females. Notably, 73% of the patients showed recovery. Common presenting symptoms included palpable lumps (45%) and pain (41%). Blood tests revealed that haemoglobin levels in children aged 2-9 years were below the usual lower limit (8.21 ± 4.88 g/dL). White blood cell counts in the same age group were abnormal, averaging 11.20 ± 8.36 × 103/µL. Platelet counts across the age span of 1 month to 17 years were elevated, with a mean of 412.33 ± 224.11× 103/µL. In conclusion, the supporting laboratory examinations frequently indicated anaemia, leukocytosis, and thrombocytosis among pediatric tumour patients. These findings underscore the importance of comprehensive diagnostic assessments in managing pediatric solid tumours.

Downloads

Download data is not yet available.

License

Creative Commons License

© 2025 Author(s). Published by Sains Medika: Jurnal Kedokteran dan Kesehatan. This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

How to Cite

Mayangsari, C. P., Raharjo, R. Y., Ardelia, A., & Pramudya, R. D. S. (2025). Clinical and epidemiological characteristics of pediatric solid tumours at Sultan Agung Islamic Hospital (2018–2023). Sains Medika: Jurnal Kedokteran Dan Kesehatan, 16(1), 10-15. https://doi.org/10.30659/sainsmed.v16i1.39770

References

AACP. (2018). Pedsap lab values. Handbook, Pediatric and Neonatal Dosage, Cl, 2018.

Adinatha, Y., & Ariawati, K. (2020). Gambaran karakteristik kanker anak di RSUP Sanglah, Bali, Indonesia periode 2008-2017. Intisari Sains Medis, 11(2): 575–581. https://doi.org/10.15562/ism.v11i2.638

Allen-Rhoades, W., Whittle, S. B., & Rainusso, N. (2018). Pediatric solid tumors in children and adolescents: An overview. Pediatrics in Review, 39(9): 444–453. https://doi.org/10.1542/pir.2017-0268

Bray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R. L., Soerjomataram, I., & Jemal, A. (2024). Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 74(3): 229-263. https://doi.org/10.3322/caac.21834

Brown, J. S., Amend, S. R., Austin, R. H., Gatenby, R. A., Hammarlund, E. U., & Pienta, K. J. (2023). Updating the definition of cancer. Molecular Cancer Research, 21(11): 1142-1147. https://doi.org/10.1158/1541-7786.MCR-23-0411

Dome, J. S., Rodriguez-Galindo, C., Spunt, S. L., & Santana, V. M. (2019). Pediatric Solid Tumors. Abeloff's Clinical Oncology (Sixth Edition), 1703-1747.e11. https://doi.org/10.1016/B978-0-323-47674-4.00092-X

Quintero Escobar, M., Maschietto, M., Krepischi, A. C., Avramovic, N., & Tasic, L. (2019). Insights into the chemical biology of childhood embryonal solid tumors by NMR-based metabolomics. Biomolecules, 9(843): 1-15. https://doi.org/10.3390/biom9120843

Fithriyah, I., Konginan, A., Maramis, M., Mahajudin, M., Muhdi, N., Margono, H., Warsiki, E., Basoeki, L., & Yitnamurti, S. (2020). The epidemiology of pediatric cancer in the palliative care unit at Dr. Soetomo General Hospital, Surabaya. Jurnal Berkala Epidemiologi, 8(1): 65–71. https://doi.org/10.20473/jbe.V8I12020.65-71

Garniasih, R. D., Windiastuti, E., & Gatot, D. (2016). Karakteristik dan kesintasan neuroblastoma pada anak di Departemen Ilmu Kesehatan Anak Fakultas Kedokteran Universitas Indonesia Rumah Sakit Cipto Mangunkusumo. Sari Pediatri, 11(1): 39-46. https://doi.org/10.14238/sp11.1.2009.39-46

Johnston, W., Erdmann, F., Newton, R., Steliarova-Foucher, E., Schüz, J., & Roman, E. (2021). Childhood cancer: Estimating regional and global incidence. Cancer Epidemiology, 71(101662): 1-12. https://doi.org/10.1016/j.canep.2019.101662

Kew, M. C. (2016). Liver Cancer. In International Encyclopedia of Public Health (Second Edition, Vol. 4). Elsevier. https://doi.org/10.1016/B978-0-12-803678-5.00255-1

Lipsick, J. (2020). A history of cancer research: Tumour suppressor genes. Cold Spring Harbor Perspectives in Biology, 12(2):1–12. https://doi.org/10.1101/cshperspect.a035907

Made Suwananta, I., Ariawati, K., N K P Widnyana, A. A., & Ayu Yani Lastariana, K. (2021). Prevalence and characteristics of pediatric solid tumours in Sanglah Hospital, Bali. SLOAP: International Journal of Health & Medical Sciences, 4(3): 322–332. https://doi.org/10.31295/ijhms.v4n3.1755

Madeddu, C., Gramignano, G., Astara, G., et al. (2018). Pathogenesis and treatment options of cancer related anemia: Perspective for a targeted mechanism-based approach. Frontiers in Physiology, 9(SEP): 1–20. https://doi.org/10.3389/fphys.2018.01294

Misra, S., & Patil, K. (2016). Advanced case of rhabdomyosarcoma of orbit mimicking orbital cellulitis. Journal of Clinical & Experimental Ophthalmology, 07(02): 2–4. https://doi.org/10.4172/2155-9570.1000533

Mulatsih, S., & Diba, V. F. (2016). Neuroblastoma pada anak usia 7 tahun: Laporan kasus. Sari Pediatri, 10(5),: 292-295. https://doi.org/10.14238/sp10.5.2009.292-5

Riskesdas. (2018). Laporan Riskesdas 2018 Kementrian Kesehatan Jawa Tengah Republik Indonesia. https://dinkesjatengprov.go.id/v2018/storage/2019/12/CETAK-LAPORAN-RISKESDAS-JATENG-2018-ACC-PIMRED.pdf . Diakses 26 Januari 2025

Rosdiana, N. (2016). Gambaran klinis dan laboratorium retinoblastoma. Sari Pediatri, 12(5): 319-322. https://doi.org/10.14238/sp12.5.2011.319-22

Sarbay, H., Okumus, M., Sertbas, I., Hacisalihoglu, U. P., Atay, A., & Malbora, B. (2020). Children with solid tumors treated in our centre. International Journal of Contemporary Pediatrics, 7(12): 2260–2266. https://doi.org/10.18203/2349-3291.ijcp20205087

Supriyadi E, Purwanto I, Armytasari I, Ritter J, Widjajanto PH, Veerman AJ. A province-wide childhood malignancy profiles in Indonesia (2010-2019): Yogyakarta Pediatric Cancer Registry. Pediatrica Indonesiana; 63(4): 226-237. https://doi.org/10.14238/pi63.4.2023.226-37

Tomáš, T., Janícek, P., Pazourek, L., & Mahdal, M. (2017). Osteosarkom. Přehledové Články, 11(6): 294–298. http://dx.doi.org/10.36290/xon.2017.054

World Health Organization. (2018). WHO Global Initiative for Childhood Cancer: an overview. https://www.who.int/docs/default-source/a-future-for-children/booklet-global-initiative-for-childhood-cancer-2-november-2020.pdf?sfvrsn=3ec028f2_1.Accessed on 1 February 2024